IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer

Oncogene

Volumn 30, Issue 44, 2011, Pages 4498-4508

  Jiang, J ^a   Liu, W ^a   Guo, X ^a   Zhang, R ^a   Zhi, Q ^a   Ji, J ^a   Zhang, J ^a,a   Chen, X ^a   Li, J ^a   Gu, Q ^a   Liu, B ^a   Zhu, Z ^a   Yu, Y ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

angiogenesis; BDKRB2; gastric carcinoma; IRX1; vasculogenic mimicry

Indexed keywords

P21 ACTIVATED KINASE 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BDKRB2 GENE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CHICK EMBRYO; CONTROLLED STUDY; HUMAN; HUMAN CELL; IRX1 GENE; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; STOMACH CANCER; TUMOR GENE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL LINE, TUMOR; CHICK EMBRYO; ENDOTHELIAL CELLS; HOMEODOMAIN PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, BRADYKININ B2; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 80455155178     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.154     Document Type: Article

References (51)

1. Alarcon P, Rodriguez-Seguel E, Fernandez-Gonzalez A, Rubio R, Gomez-Skarmeta JL. (2008). A dual requirement for Iroquois genes during Xenopus kidney development. Development 135: 3197-3207.
2. Altundag K, Elkiran ET, Altundag O. (2004). Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma. Cancer 100: 1768-1769; author reply 1769. (Pubitemid 38456359)
3. Andoh T, Akira A, Saiki I, Kuraishi Y. (2010). Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells. Peptides 31: 238-241.
4. Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA et al. (2006). A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res 8: R69.
5. Becker MB, Zulch A, Bosse A, Gruss P. (2001). Irx1 and Irx2 expression in early lung development. Mech Dev 106: 155-158. (Pubitemid 32701086)
6. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G et al. (2008). Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 68: 4494-4499.
7. Bennett KL, Romigh T, Eng C. (2009). Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis. Cancer Res 69: 9301-9305.
8. Bessard A, Fremin C, Ezan F, Fautrel A, Gailhouste L, Baffet G. (2008). RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene 27: 5315-5325.
9. Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS et al. (2009). Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther 8: 1360-1368.
10. Calderon AJ, Lavergne JA. (2005). RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential. PR Health Sci J 24: 27-33.
11. Deryugina EI, Quigley JP. (2008a). Chapter 2 Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules. Methods Enzymol 444: 21-41.
12. Deryugina EI, Quigley JP. (2008b). Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Histochem Cell Biol 130: 1119-1130.
13. Fryer BH, Field J. (2005). Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells. Cancer Lett 229: 13-23. (Pubitemid 41263406)
14. Fujimoto A, Onodera H, Mori A, Nagayama S, Yonenaga Y, Tachibana T. (2006). Tumour plasticity and extravascular circulation in ECV304 human bladder carcinoma cells. Anticancer Res 26: 59-69. (Pubitemid 43206061)
15. Galan Moya EM, Le Guelte A, Gavard J. (2009). PAKing up to the endothelium. Cell Signal 21: 1727-1737.
16. Gartel AL, Kandel ES. (2006). RNA interference in cancer. Biomol Eng 23: 17-34. (Pubitemid 43243836)
17. Getmanova EV, Chen Y, Bloom L, Gokemeijer J, Shamah S, Warikoo V et al. (2006). Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem Biol 13: 549-556. (Pubitemid 43744513)
18. Gu W, Putral L, McMillan N. (2008). siRNA and shRNA as anticancer agents in a cervical cancer model. Methods Mol Biol 442: 159-172.
19. Guo X, Liu W, Pan Y, Ni P, Ji J, Guo L et al. (2010). Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene 29: 3908-3920.
20. Gupta GP, Massague J. (2006). Cancer metastasis: building a framework. Cell 127: 679-695. (Pubitemid 44781029)
21. Hao X, Sun B, Zhang S, Zhao X. (2002). Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor. Zhonghua Yi Xue Za Zhi 82: 1298-1302.
22. Ikeda Y, Hayashi I, Kamoshita E, Yamazaki A, Endo H, Ishihara K et al. (2004). Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 64: 5178-5185. (Pubitemid 39006536)
23. Ishihara K, Kamata M, Hayashi I, Yamashina S, Majima M. (2002). Roles of bradykinin in vascular permeability and angiogenesis in solid tumor. Int Immunopharmacol 2: 499-509. (Pubitemid 34169745)
24. Kramarenko II, Bunni MA, Raymond JR, Garnovskaya MN. (2010). Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells. Mol Pharmacol 78: 126-134.
25. Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G et al. (2008). Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovasculariza-tion potential. Circ Res 103: 1335-1343.
26. Kumar R, Vadlamudi RK. (2002). Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol 193: 133-144.
27. Li X, Liu F, Li F. (2010). PAK as a therapeutic target in gastric cancer. Expert Opin Ther Targets 14: 419-433.
28. Liu F, Li X, Wang C, Cai X, Du Z, Xu H et al. (2009). Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1. Int J Cancer 125: 2511-2519.
29. Lorch JH, Thomas TO, Schmoll HJ. (2007). Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer. Cancer Res 67: 727-734. (Pubitemid 46192213)
30. Lu Y, Yu Y, Zhu Z, Xu H, Ji J, Bu L et al. (2005). Identification of a new target region by loss of heterozygosity at 5p15.33 in sporadic gastric carcinomas: genotype and phenotype related. Cancer Lett 224: 329-337. (Pubitemid 40725853)
31. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J et al. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752. (Pubitemid 29426820)
32. Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M, Shimosegawa T. (2008). Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 295: G709-G717.
33. Matsuda KM, Madoiwa S, Hasumi Y, Kanazawa T, Saga Y, Kume A et al. (2000). A novel strategy for the tumor angiogen-esis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer. Cancer Gene Ther 7: 589-596. (Pubitemid 30326895)
34. Mirshahi P, Rafii A, Vincent L, Berthaut A, Varin R, Kalantar G et al. (2009). Vasculogenic mimicry of acute leukemic bone marrow stromal cells. Leukemia 23: 1039-1048.
35. Nogueras S, Merino A, Ojeda R, Carracedo J, Rodriguez M, Martin-Malo A et al. (2008). Coupling of endothelial injury and repair: an analysis using an in vivo experimental model. Am J Physiol Heart Circ Physiol 294: H708-H713. (Pubitemid 351253282)
36. Oleinikov AV, Zhao J, Gray MD. (2005). RNA interference by mixtures of siRNAs prepared using custom oligonucleotide arrays. Nucleic Acids Res 33: e92.
37. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger Jr PM, Cohen MB et al. (2002). Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50: 189-201. (Pubitemid 34137446)
38. Shirakawa K, Kobayashi H, Sobajima J, Hashimoto D, Shimizu A, Wakasugi H. (2003). Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model. Breast Cancer Res 5: 136-139. (Pubitemid 36519406)
39. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE et al. (2001). Molecular determinants of ovarian cancer plasticity. Am J Pathol 158: 1279-1288. (Pubitemid 32281292)
40. Su M, Feng YJ, Yao LQ, Cheng MJ, Xu CJ, Huang Y et al. (2008). Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer 18: 476-486. (Pubitemid 351668302)
41. Sun B, Qie S, Zhang S, Sun T, Zhao X, Gao S et al. (2008). Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 39: 444-451. (Pubitemid 351186697)
42. Sun B, Zhang S, Zhang D, Du J, Guo H, Zhao X et al. (2006). Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep 16: 693-698.
43. Sun B, Zhang S, Zhao X, Zhang W, Hao X. (2004). Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 25: 1609-1614.
44. Tang Y, Zhou H, Chen A, Pittman RN, Field J. (2000). The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem 275: 9106-9109. (Pubitemid 30185123)
45. van der Schaft DW, Hillen F, Pauwels P, Kirschmann DA, Caster-mans K, Egbrink MG et al. (2005). Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 65: 11520-11528. (Pubitemid 41821710)
46. Veeravalli KK, Chetty C, Ponnala S, Gondi CS, Lakka SS, Fassett D et al. (2010). MMP-9, uPAR and cathepsin B silencing down-regulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice. PLoS One 5: e11583.
47. Wu J, Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K et al. (2002). Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 98: 29-35. (Pubitemid 34113414)
48. Yue WY, Chen ZP. (2005). Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem 53: 997-1002.
49. Zhang J. (2008). Morphology and mechanism research of gastric cancer vasculogenic mimicry. J Chongqing Medical University 33: 1603-1605.
50. Zhang S, Zhang D, Sun B. (2007). Vasculogenic mimicry: current status and future prospects. Cancer Lett 254: 157-164. (Pubitemid 47126687)
51. Zhang W, Bhola N, Kalyankrishna S, Gooding W, Hunt J, Seethala R et al. (2008). Kinin b2 receptor mediates induction of cyclooxygen-ase-2 and is overexpressed in head and neck squamous cell carcinomas. Mol Cancer Res 6: 1946-1956.